Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection

Virus Infection ◽

Young Children ◽

Disease Severity ◽

Syncytial Virus ◽

Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd009417.pub2 ◽

2019 ◽

Cited By ~ 1

Author(s):

Sharon L Sanders ◽

Sushil Agwan ◽

Mohamed Hassan ◽

Mieke L van Driel ◽

Chris B Del Mar

Keyword(s):

Virus Infection ◽

Young Children ◽

Immunoglobulin Treatment ◽

Syncytial Virus ◽

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

10.1542/9781610020862-part05-updated_guidance_for ◽

2017 ◽

pp. 1504-1504

Keyword(s):

Virus Infection ◽

Young Children ◽

Increased Risk ◽

Syncytial Virus ◽

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

10.1542/9781610020190-part05-updated ◽

2016 ◽

pp. 1362-1362

Keyword(s):

Virus Infection ◽

Young Children ◽

Increased Risk ◽

Syncytial Virus ◽

Age-dependent Interactions Among Clinical Characteristics, Viral Loads and Disease Severity in Young Children With Respiratory Syncytial Virus Infection

The Pediatric Infectious Disease Journal ◽

10.1097/inf.0000000000002914 ◽

2020 ◽

Vol Publish Ahead of Print ◽

Author(s):

Helena Brenes-Chacon ◽

Cristina Garcia-Mauriño ◽

Melissa Moore-Clingenpeel ◽

Sara Mertz ◽

Fang Ye ◽

...

Keyword(s):

Virus Infection ◽

Young Children ◽

Disease Severity ◽

Clinical Characteristics ◽

Viral Loads ◽

Age Dependent ◽

Syncytial Virus

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

10.1542/9781610020862-part05-updated_guidance ◽

2017 ◽

pp. 1504-1504

Keyword(s):

Virus Infection ◽

Young Children ◽

Increased Risk ◽

Syncytial Virus ◽

RSV Policy Statement —Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection. Pediatrics 2014;134(2):415–420

PEDIATRICS ◽

10.1542/peds.2014-2783 ◽

2014 ◽

Vol 134 (6) ◽

pp. 1221.1-1221 ◽

Cited By ~ 2

Keyword(s):

Virus Infection ◽

Young Children ◽

Policy Statement ◽

Increased Risk ◽

Syncytial Virus ◽

Association of TLR4 Polymorphisms with Symptomatic Respiratory Syncytial Virus Infection in High-Risk Infants and Young Children

The Journal of Immunology ◽

10.4049/jimmunol.179.5.3171 ◽

2007 ◽

Vol 179 (5) ◽

pp. 3171-3177 ◽

Cited By ~ 126

Author(s):

Agnes A. Awomoyi ◽

Prasad Rallabhandi ◽

Toni I. Pollin ◽

Eva Lorenz ◽

Marcelo B. Sztein ◽

...

Keyword(s):

High Risk ◽

Virus Infection ◽

Young Children ◽

Syncytial Virus ◽

High Risk Infants ◽

Faculty Opinions recommendation of Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1098510.554606 ◽

2007 ◽

Author(s):

Heather Jaspan

Keyword(s):

Virus Infection ◽

Young Children ◽

Syncytial Virus ◽

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

PEDIATRICS ◽

10.1542/peds.2014-1666 ◽

2014 ◽

Vol 134 (2) ◽

pp. e620-e638 ◽

Cited By ~ 147

Author(s):

Keyword(s):

Virus Infection ◽

Young Children ◽

Increased Risk ◽

Syncytial Virus ◽

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection (Technical Report)

10.1542/9781610020190-part05-updated02 ◽

2016 ◽

pp. 1363-1363

Keyword(s):

Virus Infection ◽

Young Children ◽

Increased Risk ◽

Technical Report ◽

Syncytial Virus ◽